New York, USA – July 7, 2022 – Liposomes are widely used in drug delivery systems for cancer therapy, immunomodulation, gene therapy and vaccines. In addition, the unique structure of liposomes is characterized by high biocompatibility, long circulation time, and precise targeting. With the development of liposome technology, the liposome-mediated drug delivery system will play a more important role in research applications.

As a leading biotech company, Creative Biolabs has years of experience in providing liposome development services. The advanced LipoDrive™ platform could prepare liposomes of different sizes, structures, or functions through various methods and support analysis and characterization of liposomes in all aspects. Now, Creative Biolabs has launched the one-stop liposome research solutions to use in three different applications:

• Liposomes for Brain Drug Delivery

• Liposomes for Gene Editing

• Liposomes for Immune Activation

Liposomes for Brain Drug Delivery

The blood-brain barrier (BBB) has hampered the accessibility of most therapeutic compounds to the brain for pharmacological effect in the treatment of CNS diseases. Because of biocompatibility, liposomes are exploited as drug carriers for BBB penetration.

As a liposome contract manufacturer, Creative Biolabs can design and produce distinctive liposome formulations and products, as well as liposome analysis to characterize liposome products, preliminary cell, and animal experiments. In addition, Creative Biolabs provides one-stop solutions that cover every stage of the BBB drug delivery research.

Liposomes for Gene Editing

Liposomes are the most intensively investigated gene carriers among existing delivery carriers due to their excellent biodegradability and biocompatibility. Creative Biolabs’ liposome experts have extensive experience creating liposomes to meet individual requirements and offer experimental plans that cover all stages of gene editing. Creative Biolabs manufactures serum-stable liposomes with improved endosomal escape and transfection efficiency, as well as offers one-stop solutions for liposomal gene-editing research.

Liposomes for Immune Activation

Lately, subunit vaccines have attracted much attention. Meanwhile, liposomes are the most extensively utilized type of particle carrier developed to improve the efficacy of subunit vaccines. In addition, lipid-based mRNA vaccine delivery has also become one of the most attractive and commonly used strategies.

Creative Biolabs has absolute advantages in providing professional pre-clinical vaccine platforms and a full set of vaccine analytics and assessment services. With the ability to develop liposomes for immune activation, Creative Biolabs is fully capable of the studies on liposome-based subunit vaccines and mRNA vaccines. Specifically speaking, Creative Biolabs produces liposomes of outstanding loading capacity that best suit large-scale manufacturing.

Find out more services for lip-based drug discovery at https://www.creative-biolabs.com/lipid-based-delivery.

About Creative Biolabs

Creative Biolabs, as one of the most competitive biotechnology businesses, has substantial experience in the field of drug delivery and is dedicated to offering drug delivery system development with a world-class technology platform.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/lipid-based-delivery